Taho Pharmaceuticals Ltd. (TPEX:6467)
141.00
+5.00 (3.68%)
At close: Aug 18, 2026
30.56% (1Y)
| Market Cap | 7.38B +33.0% |
| Revenue (ttm) | 1.98M -74.5% |
| Net Income | -238.34M |
| EPS | -4.58 |
| Shares Out | 52.37M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 728,228 |
| Open | 137.00 |
| Previous Close | 136.00 |
| Day's Range | 135.00 - 149.50 |
| 52-Week Range | 100.50 - 208.50 |
| Beta | -0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 20, 2026 |